Trifluoperazine
( DrugBank: Trifluoperazine / KEGG DRUG: Trifluoperazine hydrochloride, Trifluoperazine )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 283 | Acquired pure red cell aplasia | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 284 | Diamond-Blackfan anemia | 1 |
283. Acquired pure red cell aplasia
Clinical trials : 25 / Drugs : 41 - (DrugBank : 22) / Drug target genes : 17 - Drug target pathways : 99
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
284. Diamond-Blackfan anemia
Clinical trials : 41 / Drugs : 123 - (DrugBank : 34) / Drug target genes : 24 - Drug target pathways : 125
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|